RAF1 and melanoma: Furthermore, the knock-down of CRAF inhibited the progression of RAS-driven and BRAFV600K mutant melanoma by mediating the inhibition of Bcl-2 rather than by inhibiting the mitogen-activated protein kinase pathway [102].